Find out if you have a Serzone side effects claim

Serzone®, generically known as nefazodone hydrochloride, is an antidepressant for oral administration in patients battling depression often with symptoms of anxiety. In 2001, the FDA issued a revised black box warning on Serzone® after reports of events of rare but possibly life-threatening liver failure. The language the FDA required on Serzone® package labels includes a warning stating, “cases of life-threatening hepatic failure have been reported in patients treated with Serzone®.”

In January 2003, Serzone® was taken off the market in all European countries because it has been linked to serious side effects including 26 deaths from liver damage. Later in November, the drug was pulled in Canada. On May 19, 2004, Bristol Myers Squibb announced it would take Serzone® off the U.S. market. Serzone® has been widely prescribed with over 4.5 million prescriptions a year sold in the United States. Sales of Serzone® were $409 million worldwide in 2001.

Serzone® should not normally be prescribed to individuals with liver disease or with liver inflammation.  Bristol Myers Squibb advises patients taking Serzone® to contact their doctor immediately if they have any of the following symptoms:

  • Jaundice (yellowing of the skin or eyes)
  • Discolored or dark urine
  • Loss of appetite
  • Nausea
  • Abdominal (stomach) pain

If you suspect that Serzone® has injured you, you should call us now at 1-800-THE-EAGLE (1-800-843-3245) or SUBMIT A SHORT AND SIMPLE CASE FORM HERE. You may have a Serzone lawsuit and be entitled to compensation for your injuries.

Back to our personal injury law firm’s homepage. 

Let Us Help You Seek Justice

Email us information about your potential claim, or give us a call 24/7 at 1-800-THE-EAGLE (1-800-843-3245) for a free, no obligation consultation.
  • I agree that I am not a client of Goldberg & Osborne for this matter unless I sign a written fee agreement with the Firm.

  • This field is for validation purposes and should be left unchanged.